Navigation Links
Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
Date:4/9/2008

About Clinsys Clinical Research, Inc.

Clinsys Clinical Research, Inc.(R), is a therapeutically focused clinical research organization and a Jubilant Organosys company headquartered in Bedminster, New Jersey. Clinsys has operations in Raleigh, North Carolina; Philadelphia, Pennsylvania; Dusseldorf, Germany; Noida and Bangalore, India. Clinsys provides pharmaceutical, biotechnology and medical device companies a broad range of clinical research services in support of Phase I-IV drug development: project management, medical and clinical monitoring, investigator and patient recruitment, site management, biostatistics, data management, drug safety, quality assurance, regulatory services and medical writing services. Clinsys has expertise in a wide range of highly specialized therapeutic areas, including oncology, cardiovascular, central nervous system, dermatology, respiratory and allergy/immunology. Clinsys Clinical Research, Ltd., with operations in Noida and Bangalore, India, provides extensive clinical research services for Phase I-IV drug development, and operates a clinical pharmacology unit performing bioavailability and bioequivalence studies as well as bioanalytical sample analysis, clinical laboratory and pathology services. Clinsys ALTERNA(TM) (clinsysalterna.com), a division of Clinsys Clinical Research, Inc., partners with clients globally to provide customized Phase I-IV clinical trial alternative solutions to the conventional outsourcing model. For more information, visit clinsys.com.

Contact

Mitchell Winfree

919.889.2992

mwinfree@clinsys.com

Clinsys, Clinsys Clinical Research, Inc., Clinsys GPS and Global Project Solution are registered trademarks of Clinsys Clinical Research, Inc. Clinsys ALTERNA registration pending. (C) Copyright 2008 Clinsys Clinical Research, Inc. All rights reserved.


'/>"/>
SOURCE Clinsys Clinical Research, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
2. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
3. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
4. National Wrestling Coaches Association Teams Up With CSG/SportsCoatings(TM)
5. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
6. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
7. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
8. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
9. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
10. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
11. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 Australian biomarker ... important US trial of its MiStat™ prostate cancer screening ... (FDA) regulatory approval upon completion. Minomic,s proprietary ... the presence of a proprietary biomarker known as the ... of prostate cancer cells. Researchers at ...
(Date:9/18/2014)... , Sept. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... to the position of  Senior Director of Clinical Development. ... Mr. James has established and led successful global clinical ... , to facilitate the clinical development of numerous ...
(Date:9/18/2014)... MILFORD, Mass. , Sept. 18, 2014 /PRNewswire/ ... developing novel therapeutics for the treatment of RNA ... National Institutes of Health (NIH) for animal testing ... multiple viral pathogens, classified as "Special Pathogens," against ... SB 9200, derived from Spring Bank,s ...
Breaking Medicine Technology:Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2
... United States Environmental Protection Agency (EPA) announced today a ... will be screened as part of EPA,s ToxCast initiative. ... this year, involves the application of extensive and diverse ... very pleased with our contributions to ToxCast to date, ...
... Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) reports ... and Sun Pharma Global, Inc ("Sun Global") for a going ... more of their affiliates would acquire all of the outstanding ... Sun Global for a per share consideration of $4.75 in ...
Cached Medicine Technology:Odyssey Thera to Participate in Expanded EPA Initiative 2Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares 2Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares 3
(Date:9/18/2014)... (PRWEB) September 18, 2014 With ... have special functions of adjusting human body physiology, ... won great popularity with a variety of specific ... food in China reached RMB187.4 billion, up 12.0% ... during 2006-2013. , View Full Report at ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 SpineFrontier ... team and surgeon partners in Less Exposure Surgery ... SpineFrontier, Tamara authored an extensive education curriculum and ... Masters in Science in Organizational Leadership, and has ... for eleven years. Bringing her to the team ...
(Date:9/18/2014)... Dr. Suzaunna Clark, Psychologist, Life Coach and Licensed ... to be seen to be believed and 2- that ... be used. Together, both lead to hearts that heal. ... do both. , Dr. Clark offers professional ... system, which provides professional guidance on dealing with everyday ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Specialty ... in Westlake, OH, announces that they have achieved ... PowerServer, a Complete Certified Ambulatory EHR-certified system developed ... Specialty Teleradiology had a non MU compliant PACS ... their business grew from a niche in oncology ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 N-Zyme Scientifics ... successfully launching its first product a mere 8 months ... is a high performance glycan release enzyme used in ... research, and the basis for tissue pathology on Mass ... (Portsmouth, NH) for the North American market (PNGase F ...
Breaking Medicine News(10 mins):Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 3Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 4Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 3Health News:Specialty Teleradiology Attains Meaningful Use with PowerServer MU 2Health News:Specialty Teleradiology Attains Meaningful Use with PowerServer MU 3Health News:N-Zyme Scientifics Announces Successful Product Launch 2
... malnourished in Haiti, which has earned the sobriquet of ... typical signs of malnutrition include swollen bellies, orange hair, ... M.D., associate clinical professor of pediatrics at Washington University ... something about the situation and founded Meds & Food ...
... been awarded a tender to import the H5N2 vaccine for ... Ministry awarded the tender to the company, as the company’s ... among the bidding companies. The company has planned to ... weeks after the receipt of the letter from the government. ...
... to a study published on August 3, 2006, by researchers ... school students// who are physically more active show better academic ... American College of Sports Medicine has published the findings of ... Medicine & Science in Sports & Exercise. ,In ...
... help a 92-year-old woman to commit suicide.// ,Ramesh ... in court to face the charge following investigations into the ... (RCMP). ,Sharma, according to media reports, was helping ... staff member interrupted them. ,Sharma, who appeared in ...
... soft drinks in educational institutions in the state.// ... all educational intuitions in the state from Friday," Rajasthan Education ... applies to 100,000 government and private institutes where over 15 ... continue till it is proved that the contents in the ...
... Zealand have significantly reduced the number of people going for ... said that the poker machine revenue fell 28%. He also ... from pub charities to various sports and other community groups. ... calls received by the gambling helpline also reduced drastically from ...
Cached Medicine News:Health News:Crusade Against Malnutrition 2Health News:Crusade Against Malnutrition 3Health News:Physical Activity Determines Academic Performance 2Health News:Indo-Canadian Doctor Charged with Abetting Suicide Bid 2
The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
For primary and revision cases...
Medicine Products: